24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
DataTech
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Clinical Test
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:47
Group 11 strikes $20 million deal for second fund holdings, including Tipalti, Navan, and Sunbit
16:08
Investment in Israeli climate tech is shrinking at an alarming rate
14:30
Mekorot to allow small suppliers to sell it electricity
14:21
After losing 99% of its value, hospitality company Selina receives $20 million lifeline from Osprey Investments
More stories
Buzz
Most popular
Daily
Weekly
1
Tuition of terror: Qatari money flowed into U.S. universities - and now it's fueling violence
2
Tech titans line up: The leading companies ready for blockbuster IPOs in 2024
3
Israel’s Tictuk acquired by Yum! Brands, owner of KFC, Pizza Hut, and Taco Bell
4
Fintech startup Pontera raises $60 million at $550 million valuation
5
The 50 most promising Israeli startups - 2023
More news
Clinical Test
1 stories about Clinical Test
Former Teva Executive One Step Closer to Bringing Copaxone Rival to Market
31.10.17
|
Lilach Baumer
Mapi Pharma announced a successful phase II clinical trial for its Copaxone equivalent GA Depot
Please ensure Javascript is enabled for purposes of
website accessibility